Manel Pons-Perez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
TUG1: a potential endogenous reference gene for long noncoding RNA quantification in blood-based studies.
Journal: Biomarker research
Published: August 13, 2025
MicroRNA mapping of bronchial aspirate for molecular phenotyping and prognostication in patients on mechanical ventilation.
Journal: Molecular therapy. Nucleic acids
Published: March 12, 2025
Machine learning for catalysing the integration of noncoding RNA in research and clinical practice.
Journal: EBioMedicine
Published: March 08, 2024
Decoding viral and host microRNA signatures in airway-derived biosamples: Insights for biomarker discovery in viral respiratory infections.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 05, 2024
MicroRNA-centered theranostics for pulmoprotection in critical COVID-19.
Journal: Molecular therapy. Nucleic acids
Published: February 05, 2024
MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study.
Journal: British journal of pharmacology
Published: October 24, 2023
Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity.
Journal: International journal of biological macromolecules
Published: September 20, 2023
Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 13, 2022
Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS.
Journal: Emerging microbes & infections
Published: May 23, 2022
Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection.
Journal: Frontiers in immunology
Published: May 12, 2022
Last Updated: 09/26/2026